Published in Am J Pathol on June 23, 2011
Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study. Neurology (2015) 1.03
The HIF-1/glial TIM-3 axis controls inflammation-associated brain damage under hypoxia. Nat Commun (2015) 0.82
Myeloperoxidase-derived oxidants induce blood-brain barrier dysfunction in vitro and in vivo. PLoS One (2013) 0.81
Inflaming the diseased brain: a role for tainted melanins. Biochim Biophys Acta (2015) 0.79
Resveratrol confers protection against rotenone-induced neurotoxicity by modulating myeloperoxidase levels in glial cells. PLoS One (2013) 0.78
Serotonin as a putative scavenger of hypohalous acid in the brain. Biochim Biophys Acta (2015) 0.76
Effect of pioglitazone on excitotoxic neuronal damage in the mouse hippocampus. Biomol Ther (Seoul) (2015) 0.75
Octreotide ameliorates inflammation and apoptosis in acute and kindled murine PTZ paradigms. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science (2005) 14.43
Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science (2010) 12.15
Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci (2000) 10.62
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol (2010) 9.59
Myeloperoxidase: friend and foe. J Leukoc Biol (2005) 7.16
Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci (2009) 6.93
Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci (2005) 5.93
Microglia in neurodegenerative disease. Nat Rev Neurol (2010) 5.83
Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science (1998) 4.92
Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem (2002) 4.54
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation (2003) 4.36
Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature (1998) 4.34
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest (1994) 4.17
Association between myeloperoxidase levels and risk of coronary artery disease. JAMA (2001) 3.74
Debris clearance by microglia: an essential link between degeneration and regeneration. Brain (2008) 3.36
Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science (2002) 3.13
Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol (2009) 3.04
Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation (2004) 2.79
Neuronal 'On' and 'Off' signals control microglia. Trends Neurosci (2007) 2.55
Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem (2002) 2.02
Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest (2001) 2.01
Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A (2004) 1.87
Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci (2002) 1.87
Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke (1994) 1.81
Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J Neurosci (2003) 1.73
Myeloperoxidase deficiency enhances inflammation after allogeneic marrow transplantation. Am J Physiol Lung Cell Mol Physiol (2004) 1.68
Myeloperoxidase-catalyzed inactivation of alpha 1-protease inhibitor by human neutrophils. J Biol Chem (1981) 1.65
Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J Neurosci (2003) 1.58
Oxidative and inflammatory pathways in Parkinson's disease. Neurochem Res (2008) 1.49
Peroxide detoxification by brain cells. J Neurosci Res (2004) 1.46
Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res (1991) 1.45
Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res (2002) 1.42
Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit ? Acta Haematol (2000) 1.41
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice. J Neurosci (2005) 1.40
Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease. Free Radic Biol Med (2008) 1.38
Human myeloperoxidase in innate and acquired immunity. Arch Biochem Biophys (2010) 1.36
Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp Neurol (1999) 1.36
Neuronal regulation of immune responses in the central nervous system. Trends Immunol (2009) 1.33
Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp Neurol (2004) 1.30
Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. J Neurosci (2003) 1.29
Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol (1997) 1.27
Neuronal expression of myeloperoxidase is increased in Alzheimer's disease. J Neurochem (2004) 1.27
Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion. Am J Pathol (2007) 1.24
Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation. Circ Res (2008) 1.18
Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med (2004) 1.16
Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol (2007) 1.15
Augmented inducible nitric oxide synthase expression and increased NO production reduce sepsis-induced lung injury and mortality in myeloperoxidase-null mice. Am J Physiol Lung Cell Mol Physiol (2008) 1.14
Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway. J Immunol (2010) 1.12
Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense. J Immunol (2005) 1.09
Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am J Pathol (2006) 1.08
Role of microglial redox balance in modulation of neuroinflammation. Curr Opin Neurol (2009) 1.04
Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity. Glia (2007) 1.03
Oxidative cross-linking of tryptophan to glycine restrains matrix metalloproteinase activity: specific structural motifs control protein oxidation. J Biol Chem (2003) 1.00
Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease. J Biol Chem (2008) 0.98
In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone. J Neurochem (2000) 0.98
Rac1 contributes to maximal activation of STAT1 and STAT3 in IFN-gamma-stimulated rat astrocytes. J Immunol (2004) 0.96
Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J Immunol (2008) 0.96
Mice lacking myeloperoxidase are more susceptible to experimental autoimmune encephalomyelitis. J Neuroimmunol (2001) 0.94
Uptake of human eosinophil peroxidase by human neutrophils. Am J Pathol (1986) 0.92
Fluorescent dye prelabelled microglial cells migrate into organotypic hippocampal slice cultures and ramify. Eur J Neurosci (1997) 0.89
Are circulating monocytes as microglia orthologues appropriate biomarker targets for neuronal diseases? Cent Nerv Syst Agents Med Chem (2009) 0.89
Expression of myeloperoxidase enhances the chemosensitivity of leukemia cells through the generation of reactive oxygen species and the nitration of protein. Leukemia (2008) 0.86
GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation. J Neurochem (2000) 0.82
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci (2002) 4.38
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog (2009) 2.76
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci U S A (2003) 2.74
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res (2005) 2.49
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem (2004) 2.43
Body mass index and cancer risk in Korean men and women. Int J Cancer (2008) 1.89
Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. Nat Genet (2012) 1.85
New chemical constituents of Euphorbia quinquecostata and absolute configuration assignment by a convenient Mosher ester procedure carried out in NMR tubes. J Nat Prod (2002) 1.74
Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano (2011) 1.65
Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immunol (2003) 1.54
Clustering approaches to identifying gene expression patterns from DNA microarray data. Mol Cells (2008) 1.53
Natural inhibitors of carcinogenesis. Planta Med (2004) 1.43
Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol (2006) 1.42
Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.41
NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation. Mol Cell Biol (2004) 1.37
Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation. Cancer Res (2006) 1.36
Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci (2006) 1.34
Cytotoxic anticancer candidates from natural resources. Curr Med Chem Anticancer Agents (2002) 1.32
Pathogenic role of glial cells in Parkinson's disease. Mov Disord (2003) 1.25
Suppression of transient receptor potential melastatin 7 channel induces cell death in gastric cancer. Cancer Sci (2008) 1.24
o-GlcNAc transferase is activated by CaMKIV-dependent phosphorylation under potassium chloride-induced depolarization in NG-108-15 cells. Cell Signal (2007) 1.23
Liver abscess and sepsis with Bacillus pantothenticus in an immunocompetent patient: a first case report. World J Gastroenterol (2009) 1.18
Normalization of microarray data: single-labeled and dual-labeled arrays. Mol Cells (2006) 1.14
Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease. Mediators Inflamm (2013) 1.12
Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway. J Immunol (2010) 1.12
JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J Biol Chem (2002) 1.12
FX: an RNA-Seq analysis tool on the cloud. Bioinformatics (2012) 1.10
Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am J Pathol (2006) 1.08
Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells. Mol Pharmacol (2012) 1.07
Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models. Blood (2012) 1.06
Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis. Nat Commun (2012) 1.06
Computational approaches to gene prediction. J Microbiol (2006) 1.06
Cytotoxic withanolides from Acnistus arborescens. Phytochemistry (2002) 1.05
Successful treatment of digital ulcers in a scleroderma patient with continuous bilateral thoracic sympathetic block. Pain Physician (2008) 1.04
Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. Nat Prod Rep (2014) 1.04
Genome-wide association study identifies a new SMAD7 risk variant associated with colorectal cancer risk in East Asians. Int J Cancer (2014) 1.03
TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation. J Mol Cell Cardiol (2005) 1.03
Interleukin-13 and -4 induce death of activated microglia. Glia (2002) 1.02
Combined angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemia. Mol Ther (2005) 1.02
The role of bioactive compounds on the promotion of neurite outgrowth. Molecules (2012) 1.00
Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease. Mediators Inflamm (2012) 1.00
Interleukin-13 enhances cyclooxygenase-2 expression in activated rat brain microglia: implications for death of activated microglia. J Immunol (2006) 1.00
Prediction of Colorectal Cancer Risk Using a Genetic Risk Score: The Korean Cancer Prevention Study-II (KCPS-II). Genomics Inform (2012) 0.99
Bioactive constituents of the seeds of Brucea javanica. Planta Med (2002) 0.97
Mycobacterium conceptionense infection complicating face rejuvenation with fat grafting. J Med Microbiol (2010) 0.97
The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism. Int J Mol Sci (2012) 0.97
Alterations in cell proliferation related gene expressions in gastric cancer. Crit Rev Eukaryot Gene Expr (2011) 0.97
Selective Gαi subunits as novel direct activators of transient receptor potential canonical (TRPC)4 and TRPC5 channels. J Biol Chem (2012) 0.97
Rac1 contributes to maximal activation of STAT1 and STAT3 in IFN-gamma-stimulated rat astrocytes. J Immunol (2004) 0.96
Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J Immunol (2008) 0.96
Bilateral peripheral facial palsy in a patient with Human Immunodeficiency Virus (HIV) infection. Yonsei Med J (2006) 0.96
Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem (2005) 0.96
Clinical application of human adipose tissue-derived mesenchymal stem cells in progressive hemifacial atrophy (Parry-Romberg disease) with microfat grafting techniques using 3-dimensional computed tomography and 3-dimensional camera. Ann Plast Surg (2012) 0.95
Double-stranded RNA-activated protein kinase is required for the LPS-induced activation of STAT1 inflammatory signaling in rat brain glial cells. Glia (2005) 0.95
Differences in clinical features according to Boryoung and Karp genotypes of Orientia tsutsugamushi. PLoS One (2011) 0.95
DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer. Biochem Biophys Res Commun (2004) 0.94
Anti-inflammatory and anti-allergic effects of Agrimonia pilosa Ledeb extract on murine cell lines and OVA-induced airway inflammation. J Ethnopharmacol (2012) 0.94
Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model. Evid Based Complement Alternat Med (2013) 0.94
Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cells. Toxicol In Vitro (2011) 0.93
Increased expression of metallothionein is associated with irinotecan resistance in gastric cancer. Cancer Res (2004) 0.92
Repeated intratunical injection of adenovirus expressing transforming growth factor-beta1 in a rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease. Int J Androl (2007) 0.92
Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease. Free Radic Biol Med (2009) 0.91
Brucella endocarditis with splenic abscess: a report of the first case diagnosed in Korea. Yonsei Med J (2009) 0.91
Efficient gene expression system using the RTP801 promoter in the corpus cavernosum of high-cholesterol diet-induced erectile dysfunction rats for gene therapy. J Sex Med (2008) 0.91
Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-κB and p38 MAPK signaling pathways. PLoS One (2013) 0.91
Clinical risk factors for Clostridium difficile-associated diseases. Braz J Infect Dis (2012) 0.91
A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2. Hum Mol Genet (2013) 0.91
Potential cancer chemopreventive constituents of the seeds of Dipteryx odorata (tonka bean). J Nat Prod (2003) 0.90
Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism. Am J Pathol (2012) 0.90
Regulation of TLR2 expression by prostaglandins in brain glia. J Immunol (2008) 0.90
Promising therapeutics with natural bioactive compounds for improving learning and memory--a review of randomized trials. Molecules (2012) 0.90
Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model. Clin Cancer Res (2008) 0.90
An RNA aptamer that specifically binds pancreatic adenocarcinoma up-regulated factor inhibits migration and growth of pancreatic cancer cells. Cancer Lett (2011) 0.89
Gold nanorods for target selective SPECT/CT imaging and photothermal therapy in vivo. Quant Imaging Med Surg (2012) 0.89
Potential cncer chemopreventive flavonoids from the stems of Tephrosia toxicaria. J Nat Prod (2003) 0.89
Serum adiponectin is associated with smoking status in healthy Korean men. Endocr J (2008) 0.89
Assessing the Prevalence of Recurrent Neck and Shoulder Pain in Korean High School Male Students: A Cross-sectional Observational Study. Korean J Pain (2012) 0.89
Over-expression of miR-145 enhances the effectiveness of HSVtk gene therapy for malignant glioma. Cancer Lett (2012) 0.88
Ethyl pyruvate induces heme oxygenase-1 through p38 mitogen-activated protein kinase activation by depletion of glutathione in RAW 264.7 cells and improves survival in septic animals. Antioxid Redox Signal (2012) 0.88
Anti-inflammatory roles of retinoic acid in rat brain astrocytes: Suppression of interferon-gamma-induced JAK/STAT phosphorylation. Biochem Biophys Res Commun (2005) 0.88
Modulation of LPS-stimulated neuroinflammation in BV-2 microglia by Gastrodia elata: 4-hydroxybenzyl alcohol is the bioactive candidate. J Ethnopharmacol (2011) 0.88
Identification of two novel primate-specific genes in DSCR. DNA Res (2002) 0.88
Effects of astaxanthin on the production of NO and the expression of COX-2 and iNOS in LPS-stimulated BV2 microglial cells. J Microbiol Biotechnol (2008) 0.87
Sesquiterpenoids from Tithonia diversifolia with potential cancer chemopreventive activity. J Nat Prod (2002) 0.87
Serum adiponectin is associated with family history of diabetes independently of obesity and insulin resistance in healthy Korean men and women. Eur J Endocrinol (2009) 0.87
Advances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson's disease. Evid Based Complement Alternat Med (2013) 0.87
Rottlerin induces apoptosis of HT29 colon carcinoma cells through NAG-1 upregulation via an ERK and p38 MAPK-dependent and PKC δ-independent mechanism. Chem Biol Interact (2012) 0.86
Induction of microglial apoptosis by corticotropin-releasing hormone. J Neurochem (2006) 0.86
Ethanol extract of Prunella vulgaris var. lilacina inhibits HMGB1 release by induction of heme oxygenase-1 in LPS-activated RAW 264.7 cells and CLP-induced septic mice. Phytother Res (2011) 0.86
Sphingosine 1-phosphate induces vascular endothelial growth factor expression in endothelial cells. BMB Rep (2009) 0.86
Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia. Yonsei Med J (2006) 0.86